Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>

Adiponectin and resistin: As a non-invasive predictor for the severity of non-alcoholic fatty liver disease

-15% su kodu: ENG15
67,17 
Įprasta kaina: 79,02 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
67,17 
Įprasta kaina: 79,02 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 79.0200 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 10,00 

Knygos aprašymas

NAFLD has become the most prevalent cause of liver disease worldwide, and the development of NASH and fibrosis identifies the risk group with increase incidence of liver-related deaths. Fifty four obese patients with suspected fatty liver by abdominal ultrasound were subjected to full history taking and physical examination, full anthropometric measurements, laboratory studies including serum adiponectin and resistin, abdominal US, and sonar-guided liver biopsy "for pathological examination and measuring adiponetin and resistin gene expression". Also fifteen age-matched healthy non-obese subjects were included as a control group for serum adiponectin & resistin. According to the results of biopsy, patients were subdivided into NASH group patients) and non-NASH group, and the 2 groups were compared as regards different parameters. This book investigates adiponectin and resistin as non-invasive predictors of NAFLD.

Informacija

Autorius: Ahmed Salman, Soheir Abo Elfadl, Mona Hegazy,
Leidėjas: LAP LAMBERT Academic Publishing
Išleidimo metai: 2019
Knygos puslapių skaičius: 116
ISBN-10: 613989610X
ISBN-13: 9786139896103
Formatas: 220 x 150 x 8 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Adiponectin and resistin: As a non-invasive predictor for the severity of non-alcoholic fatty liver disease“

Būtina įvertinti prekę

Goodreads reviews for „Adiponectin and resistin: As a non-invasive predictor for the severity of non-alcoholic fatty liver disease“